Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kemeng Zhang

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 5, 2024
Impaired Meningeal Lymphatics and Glymphatic Pathway in Patients with White Matter HyperintensityYing Zhou, Rui Xue, Yifei Li, et al.
Cancer Letters|June 24, 2021
Suppression of oxidative phosphorylation and IDH2 sensitizes colorectal cancer to a naphthalimide derivative and mitoxantroneChaochao Ge, Yuxia Wang, Yongli Feng, et al.
Stroke and Vascular Neurology|August 1, 2023
Treatment with intravenous alteplase in ischaemic stroke patients with onset time between 4.5 and 24 hours (HOPE): protocol for a randomised, controlled, multicentre studyZhongyu Luo, Ying Zhou, Yaode He, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 5, 2024
Impaired Meningeal Lymphatics and Glymphatic Pathway in Patients with White Matter HyperintensityYing Zhou, Rui Xue, Yifei Li, et al.
Cancer Letters|June 24, 2021
Suppression of oxidative phosphorylation and IDH2 sensitizes colorectal cancer to a naphthalimide derivative and mitoxantroneChaochao Ge, Yuxia Wang, Yongli Feng, et al.
Stroke and Vascular Neurology|August 1, 2023
Treatment with intravenous alteplase in ischaemic stroke patients with onset time between 4.5 and 24 hours (HOPE): protocol for a randomised, controlled, multicentre studyZhongyu Luo, Ying Zhou, Yaode He, et al.
Pageof 4